Arama Sonuçları - R. Lor Randall

Sonuçları Daraltın
  1. 1
    Synovial Sarcoma: From Genetics to Genetic-based Animal Modeling

    Synovial Sarcoma: From Genetics to Genetic-based Animal Modeling Yazar: Malay Haldar, R. Lor Randall, Mario R. Capecchi

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Children's Oncology Group's 2013 blueprint for research: Bone tumors

    Children's Oncology Group's 2013 blueprint for research: Bone tumors Yazar: Richard Görlick, Katherine A. Janeway, Stephen L. Lessnick, R. Lor Randall, Neyssa Marina

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  3. 3
    The effect of surgical margins on outcomes for low grade MPNSTs and atypical neurofibroma

    The effect of surgical margins on outcomes for low grade MPNSTs and atypical neurofibroma Yazar: Nicholas M. Bernthal, Angelica R. Putnam, Kevin B. Jones, David Viskochil, R. Lor Randall

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    At-Risk Populations for Osteosarcoma: The Syndromes and Beyond

    At-Risk Populations for Osteosarcoma: The Syndromes and Beyond Yazar: George T. Calvert, R. Lor Randall, Kevin B. Jones, Lisa Cannon‐Albright, Stephen L. Lessnick, Joshua D. Schiffman

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    HER-2/ neu Expression in Osteosarcoma Increases Risk of Lung Metastasis and Can Be Associated With Gene Amplification

    HER-2/ neu Expression in Osteosarcoma Increases Risk of Lung Metastasis and Can Be Associated With Gene Amplification Yazar: Holly Zhou, R. Lor Randall, Arthur R. Brothman, Teresa M. Maxwell, Cheryl M. Coffin, Robert E. Goldsby

    Baskı/Yayın Bilgisi 2003
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Ewing's Sarcoma Family of Tumors: Current Management

    Ewing's Sarcoma Family of Tumors: Current Management Yazar: Mark L. Bernstein, Heinrich Kovar, Michael Paulussen, R. Lor Randall, Andreas Schuck, Lisa A. Teot, Herbert Juergensg

    Baskı/Yayın Bilgisi 2006
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  7. 7
    A Novel Role for Keratin 17 in Coordinating Oncogenic Transformation and Cellular Adhesion in Ewing Sarcoma

    A Novel Role for Keratin 17 in Coordinating Oncogenic Transformation and Cellular Adhesion in Ewing Sarcoma Yazar: Savita Sankar, Jason M. Tanner, Russell Bell, Aashi Chaturvedi, R. Lor Randall, Mary C. Beckerle, Stephen L. Lessnick

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Generative Artificial Intelligence Performs at a Second-Year Orthopedic Resident Level

    Generative Artificial Intelligence Performs at a Second-Year Orthopedic Resident Level Yazar: Zachary C. Lum, Dylon P Collins, Stanley Dennison, Lohitha Guntupalli, Soham Choudhary, Augustine M. Saiz, R. Lor Randall

    Baskı/Yayın Bilgisi 2024
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial

    A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial Yazar: Jessa D. Fogel, Vincent Y. Ng, Thomas Schubert, Jonathan A. Forsberg, R. Lor Randall, Ricardo Becker, Carol Morris, Michelle Ghert

    Baskı/Yayın Bilgisi 2024
    Tam Metin Erişim Tam Metin Erişim
    Pré-impressão
    Favorilerime ekle
    Kaydedildi:
  10. 10
    A survey to determine the zone of equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) randomized controlled trial

    A survey to determine the zone of equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) randomized controlled trial Yazar: Jessa D. Fogel, Vincent Y. Ng, Thomas Schubert, Jonathan A. Forsberg, R. Lor Randall, Ricardo Becker, Carol Morris, Michelle Ghert

    Baskı/Yayın Bilgisi 2024
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Genetic and epigenetic characterization of sarcoma stem cells across subtypes identifies EZH2 as a therapeutic target

    Genetic and epigenetic characterization of sarcoma stem cells across subtypes identifies EZH2 as a therapeutic target Yazar: Edmond F. O’Donnell, Maria Muñoz, Ryan R. Davis, Jessica Bergonio, R. Lor Randall, Clifford G. Tepper, Janai R. Carr

    Baskı/Yayın Bilgisi 2025
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis

    RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis Yazar: Kelsi Andrade, Jaime Fornetti, Ling Zhao, Scott C. Miller, R. Lor Randall, Neysi Anderson, Susan E. Waltz, Mark McHale, Alana L. Welm

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Molecular dissection of the mechanism by which EWS/FLI expression compromises actin cytoskeletal integrity and cell adhesion in Ewing sarcoma

    Molecular dissection of the mechanism by which EWS/FLI expression compromises actin cytoskeletal integrity and cell adhesion in Ewing sarcoma Yazar: Aashi Chaturvedi, Laura Hoffman, Christopher C. Jensen, Yi‐Chun Lin, Allie H. Grossmann, R. Lor Randall, Stephen L. Lessnick, Alana L. Welm, Mary C. Beckerle

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Modeling Alveolar Soft Part Sarcomagenesis in the Mouse: A Role for Lactate in the Tumor Microenvironment

    Modeling Alveolar Soft Part Sarcomagenesis in the Mouse: A Role for Lactate in the Tumor Microenvironment Yazar: Matthew L. Goodwin, Huifeng Jin, Krystal Straessler, Kyllie Smith-Fry, Ju-Fen Zhu, Michael J. Monument, Allie H. Grossmann, R. Lor Randall, Mario R. Capecchi, Kevin B. Jones

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: A report from the Children’s Oncology Group

    Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: A report from the Children’s On... Yazar: Robert E. Goldsby, Timothy M. Fan, Doojduen Villaluna, Lars M. Wagner, Michael S. Isakoff, James S. Meyer, R. Lor Randall, Sharon Lee, Grace Kim, Mark L. Bernstein, Richard Görlick, Mark Krailo, Neyssa Marina

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children's Oncology Group

    Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and t... Yazar: Andrea Ferrari, Yueh-Yun Chi, Gian Luca De Salvo, Daniel Orbach, Bernadette Brennan, R. Lor Randall, M. Beth McCarville, Jennifer O. Black, Rita Alaggio, Douglas S. Hawkins, Gianni Bisogno, Sheri L. Spunt

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group

    Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Childre... Yazar: Lisa M. Kopp, Suman Malempati, Mark Krailo, Yun Gao, Allen Buxton, Brenda J. Weigel, Thomas Hawthorne, Elizabeth Crowley, Jeffrey A. Moscow, Joel M. Reid, Víctor M. Villalobos, R. Lor Randall, Richard Görlick, Katherine A. Janeway

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Tumoral <i>TP53</i> and/or <i>CDKN2A</i> alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: A report from the Children's Oncology Group

    Tumoral <i>TP53</i> and/or <i>CDKN2A</i> alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: A report from the Children's Oncology Group Yazar: Daniel M. Lerman, Michael J. Monument, Elizabeth McIlvaine, Xiao‐qiong Liu, Dali Huang, Laura Monovich, Natalie Beeler, Richard Görlick, Neyssa Marina, Richard B. Womer, Julia A. Bridge, Mark Krailo, R. Lor Randall, Stephen L. Lessnick

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis

    The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis Yazar: Kevin B. Jones, Jared J. Barrott, Mingchao Xie, Malay Haldar, H Jin, J-F Zhu, Michael J. Monument, Tim Mosbruger, Ellen M. Langer, R. Lor Randall, Richard K. Wilson, Bradley R. Cairns, Li Ding, Mario R. Capecchi

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Neurofibromatosis Type 1–Associated MPNST State of the Science: Outlining a Research Agenda for the Future

    Neurofibromatosis Type 1–Associated MPNST State of the Science: Outlining a Research Agenda for the Future Yazar: Karlyne M. Reilly, AeRang Kim, Jaishri Blakely, Rosalie E. Ferner, David H. Gutmann, Eric Legius, Markku Miettinen, R. Lor Randall, Nancy Ratner, Nelson L. ‘Shasha’ Jumbe, Annette Bakker, David Viskochil, Brigitte C. Widemann, Douglas R. Stewart

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: